|
|
Volumn 287, Issue 2, 2002, Pages 190-192
|
|
Cost-effectiveness of homocysteine-lowering therapy to prevent coronary heart disease [3] (multiple letters)
|
|
Author keywords
Coronary disease; Cost benefit analysis; Homocysteine
|
|
Indexed keywords
FOLIC ACID;
HOMOCYSTEINE;
VITAMIN;
ALPHA TOCOPHEROL;
ASCORBIC ACID;
BETA CAROTENE;
CYANOCOBALAMIN;
PYRIDOXINE;
RIBOFLAVIN;
BLOOD;
CORONARY ARTERY ATHEROSCLEROSIS;
COST BENEFIT ANALYSIS;
DIET SUPPLEMENTATION;
ECONOMICS;
HUMAN;
NOTE;
CARDIOVASCULAR RISK;
COST EFFECTIVENESS ANALYSIS;
HEALTH CARE POLICY;
ISCHEMIC HEART DISEASE;
LETTER;
META ANALYSIS;
PRIORITY JOURNAL;
RISK FACTOR;
STATISTICAL ANALYSIS;
VALIDATION PROCESS;
VITAMIN INTAKE;
VITAMIN SUPPLEMENTATION;
CORONARY ARTERIOSCLEROSIS;
COST-BENEFIT ANALYSIS;
DIETARY SUPPLEMENTS;
FOLIC ACID;
HOMOCYSTEINE;
HUMANS;
VITAMINS;
|
|
EID: 0037045496
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.287.2.190-JLT0109-3-1 Document Type: Letter |
|
Times cited : (2)
|
|
References (0)
|